Open Access

Combined metabolic, phenomic and genomic data to prioritize atrial fibrillation-related metabolites

  • Authors:
    • Zhi-Tao Yan
    • Jin-Mei Huang
    • Wen-Li Luo
    • Ji-Wen Liu
    • Kang Zhou
  • View Affiliations

  • Published online on: March 26, 2019     https://doi.org/10.3892/etm.2019.7443
  • Pages: 3929-3934
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Metabolites in atrial fibrillation (AF) were characterized to further explore the molecular mechanisms of AF by integrating metabolic, phenomic and genomic data. Gene expression data on AF (E-GEOD-79768) were downloaded from the EMBL-EBI database, followed by identification of differentially expressed genes (DEGs) which were used to construct gene-gene network. Then, multi-omics composite networks were constructed. Subsequently, random walk with restart was expanded to a multi-omics composite network to identify and prioritize the metabolites according to the AF-related seed genes deposited in the OMIM database, the whole metabolome as candidates and the phenotype of AF. Using the interaction score among metabolites, we extracted the top 50 metabolites, and identified the top 100 co-expressed genes interacted with the top 50 metabolites. Based on the FDR <0.05, 622 DEGs were extracted. In order to demonstrate the intrinsic mode of this method, we sorted the metabolites of the composite network in descending order based on the interaction scores. The top 5 metabolites were respectively weighed potassium, sodium ion, chitin, benzo[a]pyrene-7,8-dihydrodiol-9,10-oxide, and celebrex (TN). Potassium and sodium ion possessed higher degrees in the subnetwork of the entire composite network and the co-expressed network. Metabolites such as potassium and sodium ion may provide valuable clues for early diagnostic and therapeutic targets for AF.
View Figures
View References

Related Articles

Journal Cover

May-2019
Volume 17 Issue 5

Print ISSN: 1792-0981
Online ISSN:1792-1015

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Yan Z, Huang J, Luo W, Liu J and Zhou K: Combined metabolic, phenomic and genomic data to prioritize atrial fibrillation-related metabolites. Exp Ther Med 17: 3929-3934, 2019.
APA
Yan, Z., Huang, J., Luo, W., Liu, J., & Zhou, K. (2019). Combined metabolic, phenomic and genomic data to prioritize atrial fibrillation-related metabolites. Experimental and Therapeutic Medicine, 17, 3929-3934. https://doi.org/10.3892/etm.2019.7443
MLA
Yan, Z., Huang, J., Luo, W., Liu, J., Zhou, K."Combined metabolic, phenomic and genomic data to prioritize atrial fibrillation-related metabolites". Experimental and Therapeutic Medicine 17.5 (2019): 3929-3934.
Chicago
Yan, Z., Huang, J., Luo, W., Liu, J., Zhou, K."Combined metabolic, phenomic and genomic data to prioritize atrial fibrillation-related metabolites". Experimental and Therapeutic Medicine 17, no. 5 (2019): 3929-3934. https://doi.org/10.3892/etm.2019.7443